{
  "openalex_id": "W2108304898",
  "doi": "https://doi.org/10.1053/j.ajkd.2009.03.007",
  "title": "In Reply to ‘Erythropoietin and Cancer: An Old Risk’",
  "abstract": "",
  "authors": [
    {
      "display_name": "Mark Crowther",
      "id": "A5102913684",
      "orcid": "https://orcid.org/0009-0004-6072-7735",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Mark Crowther"
    }
  ],
  "publication_year": 2009,
  "publication_date": "2009-05-21",
  "type": "article",
  "cited_by_count": 0,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S18197459",
    "display_name": "American Journal of Kidney Diseases",
    "issn_l": "0272-6386",
    "issn": [
      "0272-6386",
      "1523-6838"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320990"
  },
  "volume": "53",
  "issue": "6",
  "first_page": "1102",
  "last_page": "1103",
  "open_access": {
    "is_oa": true,
    "oa_status": "bronze",
    "oa_url": "http://www.ajkd.org/article/S0272638609006003/pdf",
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.9217421
    },
    {
      "id": "C2778534260",
      "display_name": "Erythropoietin",
      "level": 2,
      "score": 0.8011866
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.6095605
    },
    {
      "id": "C2778248108",
      "display_name": "Anemia",
      "level": 2,
      "score": 0.5840956
    },
    {
      "id": "C197934379",
      "display_name": "Adverse effect",
      "level": 2,
      "score": 0.55595726
    },
    {
      "id": "C83867959",
      "display_name": "Scopus",
      "level": 3,
      "score": 0.53257257
    },
    {
      "id": "C2781068499",
      "display_name": "Kidney cancer",
      "level": 3,
      "score": 0.45775613
    },
    {
      "id": "C177713679",
      "display_name": "Intensive care medicine",
      "level": 1,
      "score": 0.4075505
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.36984748
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.35929543
    },
    {
      "id": "C2779473830",
      "display_name": "MEDLINE",
      "level": 2,
      "score": 0.31967908
    },
    {
      "id": "C17744445",
      "display_name": "Political science",
      "level": 0,
      "score": 0.0
    },
    {
      "id": "C199539241",
      "display_name": "Law",
      "level": 1,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T11534",
      "display_name": "Erythropoietin and Anemia Treatment",
      "score": 0.9995
    },
    {
      "id": "T11914",
      "display_name": "PARP inhibition in cancer therapy",
      "score": 0.9023
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1053/j.ajkd.2009.03.007",
  "pdf_url": "http://www.ajkd.org/article/S0272638609006003/pdf",
  "retrieved_date": "2025-07-30T14:30:20.974912",
  "source_database": "OpenAlex"
}